The North America Cancer Registry Software Market would witness market growth of 9.81% CAGR during the forecast period (2019-2025). Owing to the existence of developed infrastructure, North America recorded the largest revenue share on the cancer registry software market in 2018. Increasing cancer incidence in this area due to tobacco smoking and lack of physical activity among others is driving growth in the marketplace. Hospital cancer registry will help physicians determine the outcomes of the therapy and schedule treatment accordingly. The developed and growing countries are working to implement the program in all hospitals to monitor the disease and provide a framework for impact assessment and control. Nonetheless, issues related to data protection, privacy policies, and low awareness may restrain the market growth in the near future.
As of 2018, the government & third party retained the largest share of the end-use segment. Increasing the adoption of this software by governments of developed as well as developing countries to ease the burden of cancer are accelerating market growth. Using this registry, governments can easily track the areas most affected and take proactive measures. In addition, increasing government support for software implementation in hospitals is raising revenue in the segment.
The research institutes segment is anticipated to grow at a lucrative growth rate over the forecast period due to increased research initiatives being undertaken by government and private organizations to address the growing cancer incidence. These institutes utilize software to track patients for clinical trials and to control the success of treatment programs. Companies in the pharmaceutical, biotechnology, & medical devices sector are also expected to show significant growth over the forecast period due to these industries growing their R&D for better treatment outcomes.
Based on Type, the market is segmented into Integrated and Standalone. Based on Deployment Type, the market is segmented into On-premise and Cloud-based. Based on Component, the market is segmented into Commercial and Public. Based on End User, the market is segmented into Government & Third party, Research Centers, Hospital & Medical Centers, Private Payers and Pharma Biotech & Medical Device Suppliers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Cancer Registry Software Market in North America is expected to register a CAGR of 9.81% during the forecast period (2019-2025)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, McKesson Corporation, Conduent, Incorporated, Elekta AB, Ordinal Data, Inc., Onco, Inc., C/Net Solutions, Rocky Mountain Cancer Data System, Electronic Registry System, Inc., and Himagine Solutions, Inc.
Scope of the Cancer Registry Software Market Analysis
Market Segmentation:
By Type
By Deployment Type
By Component
By End User
- Government & Third party
- Research Centers
- Hospital & Medical Centers
- Private Payers
- Pharma Biotech & Medical Device Suppliers
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- IBM Corporation
- McKesson Corporation
- Conduent, Incorporated
- Elekta AB
- Ordinal Data, Inc.
- Onco, Inc.
- C/Net Solutions
- Rocky Mountain Cancer Data System
- Electronic Registry System, Inc.
- Himagine Solutions, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cancer Registry Software Market, by Type
1.4.2 North America Cancer Registry Software Market, by Deployment Type
1.4.3 North America Cancer Registry Software Market, by Component
1.4.4 North America Cancer Registry Software Market, by End User
1.4.5 North America Cancer Registry Software Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Cancer Registry Software Market by Type
3.1 North America Integrated Cancer Registry Software Market by Country
3.2 North America Standalone Cancer Registry Software Market by Country
Chapter 4. North America Cancer Registry Software Market by Deployment Model
4.1 North America On-premise Cancer Registry Software Market by Country
4.2 North America Cloud-based Cancer Registry Software Market by Country
Chapter 5. North America Cancer Registry Software Market by Component
5.1 North America Commercial Cancer Registry Software Market by Country
5.2 North America Public Cancer Registry Software Market by Country
Chapter 6. North America Cancer Registry Software Market by End User
6.1 North America Government & Third party Market by Country
6.2 North America Research Centers Market by Country
6.3 North America Hospital & Medical Centers Market by Country
6.4 North America Private Payers Market by Country
6.5 North America Pharma biotech & medical device suppliers Market by Country
Chapter 7. North America Cancer Registry Software Market by Country
7.1 USA Cancer Registry Software Market
7.1.1 USA Cancer Registry Software Market by Type
7.1.2 USA Cancer Registry Software Market by Deployment Model
7.1.3 USA Cancer Registry Software Market by Component
7.1.4 USA Cancer Registry Software Market by End User
7.2 Canada Cancer Registry Software Market
7.2.1 Canada Cancer Registry Software Market by Type
7.2.2 Canada Cancer Registry Software Market by Deployment Model
7.2.3 Canada Cancer Registry Software Market by Component
7.2.4 Canada Cancer Registry Software Market by End User
7.3 Mexico Cancer Registry Software Market
7.3.1 Mexico Cancer Registry Software Market by Type
7.3.2 Mexico Cancer Registry Software Market by Deployment Model
7.3.3 Mexico Cancer Registry Software Market by Component
7.3.4 Mexico Cancer Registry Software Market by End User
7.4 Rest of North America Cancer Registry Software Market
7.4.1 Rest of North America Cancer Registry Software Market by Type
7.4.2 Rest of North America Cancer Registry Software Market by Deployment Model
7.4.3 Rest of North America Cancer Registry Software Market by Component
7.4.4 Rest of North America Cancer Registry Software Market by End User
Chapter 8. Company Profiles
8.1 IBM Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 McKesson Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Conduent, Incorporated
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Research & Development Expense
8.3.4 Recent strategies and developments:
8.3.4.1 Product Launches and Product Expansions:
8.4 Elekta AB
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Ordinal Data, Inc.
8.5.1 Company Overview
8.6 Onco, Inc.
8.6.1 Company Overview
8.7 C/Net Solutions
8.7.1 Company Overview
8.8 Rocky Mountain Cancer Data System
8.8.1 Company Overview
8.9 Electronic Registry System, Inc.
8.9.1 Company Overview
8.1 Himagine Solutions, Inc.
8.10.1 Company Overview
TABLE 1 Global Cancer Registry Software Market, 2015 - 2018, USD Thousands
TABLE 2 Global Cancer Registry Software Market, 2019 - 2025, USD Thousands
TABLE 3 North America Cancer Registry Software Market by Type, 2015 - 2018, USD Thousands
TABLE 4 North America Cancer Registry Software Market by Type, 2019 - 2025, USD Thousands
TABLE 5 North America Integrated Cancer Registry Software Market by Country, 2015 - 2018, USD Thousands
TABLE 6 North America Integrated Cancer Registry Software Market by Country, 2019 - 2025, USD Thousands
TABLE 7 North America Standalone Cancer Registry Software Market by Country, 2015 - 2018, USD Thousands
TABLE 8 North America Standalone Cancer Registry Software Market by Country, 2019 - 2025, USD Thousands
TABLE 9 North America Cancer Registry Software Market by Deployment Model, 2015 - 2018, USD Thousands
TABLE 10 North America Cancer Registry Software Market by Deployment Model, 2019 - 2025, USD Thousands
TABLE 11 North America On-premise Cancer Registry Software Market by Country, 2015 - 2018, USD Thousands
TABLE 12 North America On-premise Cancer Registry Software Market by Country, 2019 - 2025, USD Thousands
TABLE 13 North America Cloud-based Cancer Registry Software Market by Country, 2015 - 2018, USD Thousands
TABLE 14 North America Cloud-based Cancer Registry Software Market by Country, 2019 - 2025, USD Thousands
TABLE 15 North America Cancer Registry Software Market by Component, 2015 - 2018, USD Thousands
TABLE 16 North America Cancer Registry Software Market by Component, 2019 - 2025, USD Thousands
TABLE 17 North America Commercial Cancer Registry Software Market by Country, 2015 - 2018, USD Thousands
TABLE 18 North America Commercial Cancer Registry Software Market by Country, 2019 - 2025, USD Thousands
TABLE 19 North America Public Cancer Registry Software Market by Country, 2015 - 2018, USD Thousands
TABLE 20 North America Public Cancer Registry Software Market by Country, 2019 - 2025, USD Thousands
TABLE 21 North America Cancer Registry Software Market by End User, 2015 - 2018, USD Thousands
TABLE 22 North America Cancer Registry Software Market by End User, 2019 - 2025, USD Thousands
TABLE 23 North America Government & Third party Market by Country, 2015 - 2018, USD Thousands
TABLE 24 North America Government & Third party Market by Country, 2019 - 2025, USD Thousands
TABLE 25 North America Research Centers Market by Country, 2015 - 2018, USD Thousands
TABLE 26 North America Research Centers Market by Country, 2019 - 2025, USD Thousands
TABLE 27 North America Hospital & Medical Centers Market by Country, 2015 - 2018, USD Thousands
TABLE 28 North America Hospital & Medical Centers Market by Country, 2019 - 2025, USD Thousands
TABLE 29 North America Private Payers Market by Country, 2015 - 2018, USD Thousands
TABLE 30 North America Private Payers Market by Country, 2019 - 2025, USD Thousands
TABLE 31 North America Pharma biotech & medical device suppliers Market by Country, 2015 - 2018, USD Thousands
TABLE 32 North America Pharma biotech & medical device suppliers Market by Country, 2019 - 2025, USD Thousands
TABLE 33 North America Cancer Registry Software Market by Country, 2015 - 2018, USD Thousands
TABLE 34 North America Cancer Registry Software Market by Country, 2019 - 2025, USD Thousands
TABLE 35 USA Cancer Registry Software Market, 2015 - 2018, USD Thousands
TABLE 36 USA Cancer Registry Software Market, 2019 - 2025, USD Thousands
TABLE 37 USA Cancer Registry Software Market by Type, 2015 - 2018, USD Thousands
TABLE 38 USA Cancer Registry Software Market by Type, 2019 - 2025, USD Thousands
TABLE 39 USA Cancer Registry Software Market by Deployment Model, 2015 - 2018, USD Thousands
TABLE 40 USA Cancer Registry Software Market by Deployment Model, 2019 - 2025, USD Thousands
TABLE 41 USA Cancer Registry Software Market by Component, 2015 - 2018, USD Thousands
TABLE 42 USA Cancer Registry Software Market by Component, 2019 - 2025, USD Thousands
TABLE 43 USA Cancer Registry Software Market by End User, 2015 - 2018, USD Thousands
TABLE 44 USA Cancer Registry Software Market by End User, 2019 - 2025, USD Thousands
TABLE 45 Canada Cancer Registry Software Market, 2015 - 2018, USD Thousands
TABLE 46 Canada Cancer Registry Software Market, 2019 - 2025, USD Thousands
TABLE 47 Canada Cancer Registry Software Market by Type, 2015 - 2018, USD Thousands
TABLE 48 Canada Cancer Registry Software Market by Type, 2019 - 2025, USD Thousands
TABLE 49 Canada Cancer Registry Software Market by Deployment Model, 2015 - 2018, USD Thousands
TABLE 50 Canada Cancer Registry Software Market by Deployment Model, 2019 - 2025, USD Thousands
TABLE 51 Canada Cancer Registry Software Market by Component, 2015 - 2018, USD Thousands
TABLE 52 Canada Cancer Registry Software Market by Component, 2019 - 2025, USD Thousands
TABLE 53 Canada Cancer Registry Software Market by End User, 2015 - 2018, USD Thousands
TABLE 54 Canada Cancer Registry Software Market by End User, 2019 - 2025, USD Thousands
TABLE 55 Mexico Cancer Registry Software Market, 2015 - 2018, USD Thousands
TABLE 56 Mexico Cancer Registry Software Market, 2019 - 2025, USD Thousands
TABLE 57 Mexico Cancer Registry Software Market by Type, 2015 - 2018, USD Thousands
TABLE 58 Mexico Cancer Registry Software Market by Type, 2019 - 2025, USD Thousands
TABLE 59 Mexico Cancer Registry Software Market by Deployment Model, 2015 - 2018, USD Thousands
TABLE 60 Mexico Cancer Registry Software Market by Deployment Model, 2019 - 2025, USD Thousands
TABLE 61 Mexico Cancer Registry Software Market by Component, 2015 - 2018, USD Thousands
TABLE 62 Mexico Cancer Registry Software Market by Component, 2019 - 2025, USD Thousands
TABLE 63 Mexico Cancer Registry Software Market by End User, 2015 - 2018, USD Thousands
TABLE 64 Mexico Cancer Registry Software Market by End User, 2019 - 2025, USD Thousands
TABLE 65 Rest of North America Cancer Registry Software Market, 2015 - 2018, USD Thousands
TABLE 66 Rest of North America Cancer Registry Software Market, 2019 - 2025, USD Thousands
TABLE 67 Rest of North America Cancer Registry Software Market by Type, 2015 - 2018, USD Thousands
TABLE 68 Rest of North America Cancer Registry Software Market by Type, 2019 - 2025, USD Thousands
TABLE 69 Rest of North America Cancer Registry Software Market by Deployment Model, 2015 - 2018, USD Thousands
TABLE 70 Rest of North America Cancer Registry Software Market by Deployment Model, 2019 - 2025, USD Thousands
TABLE 71 Rest of North America Cancer Registry Software Market by Component, 2015 - 2018, USD Thousands
TABLE 72 Rest of North America Cancer Registry Software Market by Component, 2019 - 2025, USD Thousands
TABLE 73 Rest of North America Cancer Registry Software Market by End User, 2015 - 2018, USD Thousands
TABLE 74 Rest of North America Cancer Registry Software Market by End User, 2019 - 2025, USD Thousands
TABLE 75 Key information – IBM Corporation
TABLE 76 Key Information – McKesson Corporation
TABLE 77 Key Information –Conduent, Incorporated
TABLE 78 key Information – Elekta AB
TABLE 79 Key Information – Ordinal Data, Inc.
TABLE 80 Key Information – Onco, Inc.
TABLE 81 Key Information – C/Net Solutions
TABLE 82 Key Information – Rocky Mountain Cancer Data System
TABLE 83 key Information – Electronic Registry System, Inc.
TABLE 84 Key information –Himagine Solutions, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: IBM Corporation